NEW YORK, Nov. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Safety First Trust Series 2007-4...
Akorn, Inc. (AMEX: AKN) today announced that it has signed an Exclusive Supply Agreement with PrimaPharm, Inc., a privately-held...
Akorn, Inc. (AMEX:AKN) today announced that its common stock listing application for the Nasdaq Global Market (Nasdaq) has been...
Akorn, Inc. (AMEX: AKN) today announced the positive results of a Phase III pivotal trial for Akten?. The clinical trial was a...
Akorn, Inc. (AMEX: AKN) today announced that it has signed a Definitive Agreement with Azad Pharma, a privately-held...
Akorn, Inc. (AMEX: AKN) and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to...
Akorn, Inc. (AMEX:AKN) and Serum Institute of India, Ltd. today announced that they have entered into a Definitive Development...
Akorn, Inc. (AMEX: AKN) today announced that it has added two injectable drug products to its API Supply and Margin Sharing...
Akorn, Inc. (AMEX:AKN) today reported net sales of $14.5 million for the third quarter 2006, an increase of 32% vs. third quarter...
Akorn, Inc. (AMEX:AKN) announced today that its third quarter 2006 earnings release has been scheduled for Monday, October 30...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads